Skip to content
1644-Endothelial Nanovesicles for Targeted Ischemic Rescue episode artwork

Oct 4, 2026 23 min

1644-Endothelial Nanovesicles for Targeted Ischemic Rescue

from Paper Talk

This research introduces CeO2-NMUiECs, a sophisticated dual-targeting nanotherapeutic designed to treat ischemic diseases by repairing damaged blood vessels. Scientists engineered these nanovesicles from iPSC-derived endothelial cells and armed them with antioxidant ceria nanozymes to survive the toxic, oxygen-depleted environments of injured tissues. The platform leverages a natural homing mechanism to navigate directly to sites of injury, where it simultaneously neutralizes harmful reactive oxygen species and delivers pro-angiogenic proteins to stimulate vessel growth. Rigorous testing across diverse models—including stroke, heart attack, and bone necrosis—demonstrated that the treatment significantly restores organ function and promotes tissue regeneration. By merging biological signaling with catalytic chemistry, this universal strategy transforms passive drug carriers into active agents capable of rescuing the ischemic endothelium. References: Jiang H, Wang Y, Huang H, et al. Universal catalytic endothelial lineage nanovesicles for targeting and rescuing ischemic endothelium[J]. Cell Reports Medicine, 2026, 7(8). 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1644-Endothelial Nanovesicles for Targeted Ischemic Rescue

0:00 23:33

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 23 minutes long.

When was this Paper Talk episode published?

This episode was published on October 4, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.